These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12077923)

  • 1. [Cerebral glucose metabolism in Down syndrome using positron emission tomography].
    Balogh E; Lengyel Z; Emri M; Szikszai E; Esik O; Kollár J; Sikula J; Trón L; Oláh E
    Orv Hetil; 2002 May; 143(21 Suppl 3):1304-7. PubMed ID: 12077923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of increased cerebral FDG uptake in Down syndrome patients.
    Lengyel Z; Balogh E; Emri M; Szikszai E; Kollár J; Sikula J; Esik O; Trón L; Oláh E
    Pediatr Neurol; 2006 Apr; 34(4):270-5. PubMed ID: 16638500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
    Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
    Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
    Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
    Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral glucose metabolism in autistic children. Study and positron emission tomography].
    De Volder AG; Bol A; Michel C; Cogneau M; Goffinet AM
    Acta Neurol Belg; 1988; 88(2):75-90. PubMed ID: 3260437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral glucose metabolism is normal in young adults with Down syndrome.
    Schapiro MB; Grady CL; Kumar A; Herscovitch P; Haxby JV; Moore AM; White B; Friedland RP; Rapoport SI
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):199-206. PubMed ID: 2137464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal pattern of cerebral glucose metabolic rates involving language areas in young adults with Down syndrome.
    Azari NP; Horwitz B; Pettigrew KD; Grady CL; Haxby JV; Giacometti KR; Schapiro MB
    Brain Lang; 1994 Jan; 46(1):1-20. PubMed ID: 8131038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
    Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
    J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Haginoya K; Togashi N; Kaneta T; Hino-Fukuyo N; Ishitobi M; Kakisaka Y; Uematsu M; Inui T; Okubo Y; Sato R; Miyabayashi T; Arai A; Ogiwara I; Mazaki E; Yamakawa K; Iinuma K; Kure S
    Epilepsy Res; 2018 Nov; 147():9-14. PubMed ID: 30176532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral glucose metabolism on positron emission tomography of children.
    Shan ZY; Leiker AJ; Onar-Thomas A; Li Y; Feng T; Reddick WE; Reutens DC; Shulkin BL
    Hum Brain Mapp; 2014 May; 35(5):2297-309. PubMed ID: 23897639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenticular nuclei to thalamic ratio on PET is useful for diagnosis of GLUT1 deficiency syndrome.
    Natsume J; Ishihara N; Azuma Y; Nakata T; Takeuchi T; Tanaka M; Sakaguchi Y; Okai Y; Ito Y; Yamamoto H; Ohno A; Kidokoro H; Hattori A; Nabatame S; Kato K
    Brain Dev; 2021 Jan; 43(1):69-77. PubMed ID: 32739099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy.
    Joo EY; Hong SB; Han HJ; Tae WS; Kim JH; Han SJ; Seo DW; Lee KH; Hong SC; Lee M; Kim S; Kim BT
    Brain; 2005 Aug; 128(Pt 8):1802-10. PubMed ID: 15872014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
    Engler H; Lundberg PO; Ekbom K; Nennesmo I; Nilsson A; Bergström M; Tsukada H; Hartvig P; Långström B
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of positron emission tomography to determine cerebral glucose utilization in conscious infant monkeys.
    Moore AH; Cherry SR; Pollack DB; Hovda DA; Phelps ME
    J Neurosci Methods; 1999 May; 88(2):123-33. PubMed ID: 10389658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain fluorodeoxyglucose PET in adrenoleukodystrophy.
    Salsano E; Marotta G; Manfredi V; Giovagnoli AR; Farina L; Savoiardo M; Pareyson D; Benti R; Uziel G
    Neurology; 2014 Sep; 83(11):981-9. PubMed ID: 25098542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.